BIOMAT Database Logo BIOMAT Database Logo

Gliclazide directly inhibits arginine-induced glucagon release. 2002

Kenan Cejvan, and David H Coy, and Jens Juul Holst, and Erol Cerasi, and Suad Efendic
Department of Molecular Medicine, Endocrine and Diabetes Unit, Karolinska Hospital and Institute, Stockholm, Sweden. kenan.cejvan@molmed.ki.se

Arginine-stimulated insulin and somatostatin release is enhanced by the sulfonylurea gliclazide. In contrast, gliclazide inhibits the glucagon response. The aim of the present study was to investigate whether this inhibition of glucagon release was mediated by a direct suppressive effect of gliclazide or was secondary to the paracrine effect of released somatostatin. To eliminate the paracrine effects of somatostatin, we first perfused isolated rat pancreata with a medium supplemented with 23% of the standard calcium content. Second, we perifused isolated rat islets with a novel and highly specific antagonist of type 2 somatostatin receptor, DC-41-33 (2 micro mol/l), which fully antagonizes the suppressive somatostatin effect on rat A cells. Gliclazide (30 micro mol/l) inhibited glucagon release by 54% in the perfusion experiments, whereas the somatostatin response was nearly abolished. In islet perifusions with DC-41-33, arginine-induced glucagon release was inhibited by 66%. We therefore concluded that gliclazide inhibits glucagon release by a direct action on the pancreatic A cell.

UI MeSH Term Description Entries
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D008297 Male Males
D010179 Pancreas A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D010456 Peptides, Cyclic Peptides whose amino acid residues are linked together forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS; some are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL). Circular Peptide,Cyclic Peptide,Cyclic Peptides,Cyclopeptide,Orbitide,Circular Peptides,Cyclopeptides,Orbitides,Peptide, Circular,Peptide, Cyclic,Peptides, Circular
D005907 Gliclazide An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion. Diabrezide,Diaglyk,Diaikron,Diamicron,Gen-Gliclazide,Gliklazid,Glyade,Glyclazide,Novo-Gliclazide,S-1702,S-852,Gen Gliclazide,Novo Gliclazide,S 1702,S 852,S1702,S852
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001120 Arginine An essential amino acid that is physiologically active in the L-form. Arginine Hydrochloride,Arginine, L-Isomer,DL-Arginine Acetate, Monohydrate,L-Arginine,Arginine, L Isomer,DL Arginine Acetate, Monohydrate,Hydrochloride, Arginine,L Arginine,L-Isomer Arginine,Monohydrate DL-Arginine Acetate
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone
D013453 Sulfonylurea Compounds A class of compounds in which a sulfone functional group is attached to UREA. Compounds, Sulfonylurea

Related Publications

Kenan Cejvan, and David H Coy, and Jens Juul Holst, and Erol Cerasi, and Suad Efendic
Gliclazide directly suppresses arginine-induced glucagon secretion.
July 1994, Diabetes research and clinical practice,
Kenan Cejvan, and David H Coy, and Jens Juul Holst, and Erol Cerasi, and Suad Efendic
Sulphonylurea (glubenclamide) enhances somatostatin and inhibits glucagon release induced by arginine.
March 1980, Acta physiologica Scandinavica,
Kenan Cejvan, and David H Coy, and Jens Juul Holst, and Erol Cerasi, and Suad Efendic
The possible role of calmodulin in the arginine-induced glucagon release.
November 1984, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Kenan Cejvan, and David H Coy, and Jens Juul Holst, and Erol Cerasi, and Suad Efendic
Diphasic glucagon release induced by arginine in the perfused rat pancreas.
September 1972, Nature: New biology,
Kenan Cejvan, and David H Coy, and Jens Juul Holst, and Erol Cerasi, and Suad Efendic
Cigarettes smoking inhibits arginine-induced insulin release in man.
January 1978, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Kenan Cejvan, and David H Coy, and Jens Juul Holst, and Erol Cerasi, and Suad Efendic
Circulating insulin inhibits glucagon secretion induced by arginine in type 1 diabetes.
January 2000, European journal of endocrinology,
Kenan Cejvan, and David H Coy, and Jens Juul Holst, and Erol Cerasi, and Suad Efendic
Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion.
January 2019, Nature communications,
Kenan Cejvan, and David H Coy, and Jens Juul Holst, and Erol Cerasi, and Suad Efendic
Glibenclamide stimulates and glucose inhibits glucagon release induced by calcium deprivation.
June 1984, Diabetes,
Kenan Cejvan, and David H Coy, and Jens Juul Holst, and Erol Cerasi, and Suad Efendic
Modulation of arginine-induced glucagon release by epinephrine and glucose levels in man.
June 1983, The Journal of clinical endocrinology and metabolism,
Kenan Cejvan, and David H Coy, and Jens Juul Holst, and Erol Cerasi, and Suad Efendic
Atrial natriuretic peptide inhibits osmolality-induced arginine vasopressin release in man.
July 1988, Clinical science (London, England : 1979),
Copied contents to your clipboard!